Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Lexington. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Lexington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This trial will evaluate whether the immune-sensitizing effects of immunotherapy (Pembrolizumab) and radiation with or without a PARP-inhibitor (Olaparib) will increase the effects of immunotherapy in men with high-risk localized prostate cancer.
Sponsor: Zin W Myint
Check if you qualify for this prostate cancer clinical trial in Lexington, KY
If you're searching for prostate cancer treatment options in Lexington, KY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lexington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.